×

Month: March 2019

Cognitive biases often underpin objections to life extension.
A cognitive bias is a systematic deviation from rational thought that can influence people's reasoning without them even noticing. Several cognitive biases have been observed and studies over the past few decades, demonstrably influencing decision-making, self-perception, and preferences while affecting many human activities. Naturally, cognitive biases have a measurable effect on the field of life...
A new review discusses how neutrophils release toxic substances into the body under inflammatory conditions, detailing one of the ways in which chronic inflammation causes long-term damage. Casting a deadly NET As we age, we suffer from the ever-increasing chronic inflammation known as inflammaging. This persistent, smoldering background of low-grade inflammation harms wound healing and...
On July 11-12th, we return to the Cooper Union in New York City for our second annual Ending Age-Related Diseases conference, which focuses on the progress in aging research as well as the business side of biotech. We will be bringing you the latest aging research, investment, and business knowledge from some of the top...
As Undoing Aging 2019 in Berlin approaches, I have been reflecting on the previous year and the things that I am most looking forward to this year. So, today, as a journalist and longevity advocate, I am going to be sharing some of my personal musings and thoughts about this important event with you. First...
Scientists have shown that the removal of non-dividing senescent cells, which are normally associated with aging, also appears to prevent Type 1 diabetes in diabetic mouse strains. Clearing senescent beta cells prevents T1 diabetes Type 1 diabetes (T1D) is a chronic condition in which the pancreas produces little or no insulin. Insulin is a hormone...
Samsara Therapeutics has completed a seed financing round in collaboration with Apollo Ventures, a venture capital company and biotech incubator that supports longevity research and treatments for age-related diseases. Samsara Therapeutics, Inc. ("Samsara,") a platform biotechnology startup engaged in the discovery and development of compounds that address the primary molecular causes of aging, announced today...